Fennec Pharmaceuticals Inc (FENC)
9.07
-0.17
(-1.84%)
USD |
NASDAQ |
Apr 24, 16:00
9.11
+0.04
(+0.44%)
After-Hours: 20:00
Fennec Pharmaceuticals Total Liabilities (Quarterly): 38.49M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.49M |
| September 30, 2023 | 29.56M |
| June 30, 2023 | 29.16M |
| March 31, 2023 | 29.16M |
| December 31, 2022 | 29.51M |
| September 30, 2022 | 27.62M |
| June 30, 2022 | 7.027M |
| March 31, 2022 | 6.625M |
| December 31, 2021 | 6.642M |
| September 30, 2021 | 7.001M |
| June 30, 2021 | 5.834M |
| March 31, 2021 | 2.892M |
| December 31, 2020 | 2.347M |
| September 30, 2020 | 2.885M |
| June 30, 2020 | 3.19M |
| March 31, 2020 | 1.907M |
| December 31, 2019 | 2.271M |
| September 30, 2019 | 0.905M |
| June 30, 2019 | 1.353M |
| March 31, 2019 | 1.451M |
| December 31, 2018 | 1.637M |
| September 30, 2018 | 2.076M |
| June 30, 2018 | 0.847M |
| March 31, 2018 | 1.173M |
| December 31, 2017 | 1.644M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.03M |
| June 30, 2017 | 0.58M |
| March 31, 2017 | 0.427M |
| December 31, 2016 | 0.402M |
| September 30, 2016 | 0.36M |
| June 30, 2016 | 0.451M |
| March 31, 2016 | 0.345M |
| December 31, 2015 | 0.471M |
| September 30, 2015 | 0.431M |
| June 30, 2015 | 0.759M |
| March 31, 2015 | 1.123M |
| December 31, 2014 | 1.759M |
| September 30, 2014 | 3.901M |
| June 30, 2014 | 5.707M |
| March 31, 2014 | 5.729M |
| December 31, 2013 | 3.207M |
| September 30, 2013 | 4.767M |
| June 30, 2013 | 3.459M |
| March 31, 2013 | 11.00M |
| December 31, 2012 | 7.322M |
| September 30, 2012 | 1.646M |
| June 30, 2012 | 1.555M |
| March 31, 2012 | 2.162M |
| December 31, 2011 | 5.471M |
| September 30, 2011 | 9.941M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.905M
Minimum
Sep 2019
38.49M
Maximum
Dec 2023
12.34M
Average
6.625M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 137.21B |
| OptiNose Inc | 194.34M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.86M |
| Shareholders Equity (Quarterly) | -11.62M |
| Debt to Equity Ratio | -2.661 |
| Current Ratio | 3.556 |
| Net Debt Paydown Yield | -0.41% |